"Uncovering Mechanisms to Reduce ALS Symptoms through Targeting Inflammation"

Research suggests that structural changes in neurons activate immune cells, leading to inflammation and reduced motor function in people with ALS. A study found that blocking inflammation with a semi-synthetic drug derived from the Ashwagandha plant can restore synaptic connections, offering a potential treatment for ALS and other inflammation-related diseases like Alzheimer’s. The findings provide insight into the correlation between neuron changes and immune responses, offering hope for new therapeutic approaches.